TotalMarketCap

Indaptus Therapeutics

INDPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$483.781 M

$3.15 -4.54%

Close of 6 Nov 2026

As of 6 Nov 2026, Indaptus Therapeutics (INDP) has a market capitalization of $483.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$20.8M

Loss-making

Shares outstanding

133,242,324

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #189Capricor TherapeuticsCAPR$499.4M
  2. #190DiaMedica TherapeuticsDMAC$488.6M
  3. #191Indaptus TherapeuticsINDP$483.8M
  4. #192Crescent BiopharmaCBIO$482.1M
  5. #193CytomX TherapeuticsCTMX$467.4M

What if Indaptus Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$183,856.20

Per share 58,367× higher

Bitcoin $1.53T

$9,948.14

Per share 3,158× higher

Apple $5.02T

$32,658.81

Per share 10,368× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Indaptus Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.